Abstract
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.
| Original language | English |
|---|---|
| Pages (from-to) | 1596-1609 |
| Number of pages | 14 |
| Journal | Drug Discovery Today |
| Volume | 23 |
| Issue number | 9 |
| Early online date | 5 May 2018 |
| DOIs | |
| Publication status | Published - Sept 2018 |
Funding
This work was supported by the European Union's Horizon2020 MSCA Program under grant agreement 675899 (FRAGNET). This work was supported by the European Union’s Horizon2020 MSCA Program under grant agreement 675899 (FRAGNET).
| Funders | Funder number |
|---|---|
| European Union's Horizon2020 MSCA | |
| European Union’s Horizon2020 MSCA | |
| Horizon 2020 Framework Programme | 675899 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 9 Industry, Innovation, and Infrastructure
-
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics of 'When fragments link: a bibliometric perspective on the development of fragment-based drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver